Patents by Inventor John Neville Hague

John Neville Hague has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid pharmaceutical compositions comprising thyroid hormones
    Publication number: 20040266877
    Abstract: There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; which has utility in the treatment of disorders associated with an impairment of the thyroid hormone function in animals including human beings. The liquid composition may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray.
    Type: Application
    Filed: March 15, 2004
    Publication date: December 30, 2004
    Inventors: Jeffrey Dickinson, Karrar Ahmad Khan, John Neville Hague, Alan Smith
  • Liquid pharmaceutical compositions comprising thyroid hormones
    Patent number: 6706255
    Abstract: Liquid pharmaceutical compositions comprising at least one thyroid hormone, ethanol, a pH adjusting agent, and water are disclosed. The compositions may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray, and are useful in the treatment of disorders associated with an impairment of thyroid hormone function in animals including human beings.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: March 16, 2004
    Assignee: Abbott GmbH & Co., KG
    Inventors: Jeffrey Dickinson, Karrar Ahmad Khan, John Neville Hague, Alan Smith
  • Liquid pharmaceutical compositions comprising thyroid hormones
    Publication number: 20030130351
    Abstract: Liquid pharmaceutical compositions comprising at least one thyroid hormone, ethanol, a pH adjusting agent, and water are disclosed. The compositions may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray, and are useful in the treatment of disorders associated with an impairment of thyroid hormone function in animals including human beings.
    Type: Application
    Filed: September 13, 2002
    Publication date: July 10, 2003
    Applicant: Knoll Pharmaceutical Company
    Inventors: Jeffrey Dickinson, Karrar Ahmad Khan, John Neville Hague, Alan Smith
  • Liquid pharmaceutical compositions comprising thyroid hormones
    Patent number: 6458842
    Abstract: There is disclosed a liquid pharmaceutical composition comprising a therapeutic agent which comprises: one or more thyroid hormone or hormones; from about 40% to about 96% ethanol by volume; a pH adjusting agent so that the measured pH of the composition is from about 9 to about 12; and from about 4% to about 50% water by volume; which has utility in the treatment of disorders associated with an impairment of the thyroid hormone function in animals including human beings. The liquid composition may be delivered by a metered dosage delivery system such as an aerosol or pump-action spray.
    Type: Grant
    Filed: July 31, 1996
    Date of Patent: October 1, 2002
    Assignee: Knoll Aktiengesellschaft
    Inventors: Jeffrey Dickinson, Karrar Ahmad Khan, John Neville Hague, Alan Smith